![](/media/vdqhqzem/salmon.png)
Uppsala Reports editor
@UMCGlobalSafety
Adverse effects to medicines are not just physical in nature, but can manifest as behavioural side-effects too. How do we diagnose and treat these complex ADRs?
Drug-induced impulse control disorders have the potential to negatively impact overall quality of life, but are especially hard to identify, diagnose, and treat. In the latest Drug Safety Matters podcast, Michele Fusaroli of the University of Bologna describes which types of medicines are most likely to cause these impulsive behaviours, and how listening to patient stories can be a huge help in their detection and treatment.
Subscribe by visiting the Drug Safety Matters website or listen to the podcast here:
The traditional “drug-event combination” approach is too simplistic for complex side effects such as behavioural changes. We must adjust our methodology to address this intricacy.
Research / 29 May 2024
Duplicate reports are a big problem when it comes to signal detection, but with the help of machine learning and new ways of comparing reports, we may more effectively detect them.
Research / 25 April 2024
When it comes to pharmacovigilance in older patients, age alone is insufficient as a measure of adverse reaction risk. Here is what we should consider instead.
Research / 13 May 2024